Shares of Cochlear Limited (OTCMKTS:CHEOF – Get Free Report) rose 2.8% during mid-day trading on Tuesday. The company traded as high as $94.78 and last traded at $94.62. Approximately 200 shares changed hands during mid-day trading, a decline of 85% from the average daily volume of 1,312 shares. The stock had previously closed at $92.00.
Cochlear Price Performance
The firm has a fifty day simple moving average of $94.04 and a two-hundred day simple moving average of $108.51.
Cochlear Company Profile
Cochlear Limited is an Australian medical device company that develops, manufactures and supplies implantable hearing solutions for people with significant hearing loss. Its products are designed to bypass damaged parts of the ear and stimulate the auditory nerve, helping eligible users perceive sound.
The company’s principal offerings include cochlear implants, sound processors and related accessories, as well as bone-conduction and other implantable hearing systems. Cochlear also provides clinical support, professional services, rehabilitation resources and software intended to help patients and hearing-care professionals manage and optimize these devices.
Cochlear traces its origins to research by Australian scientist Dr.
See Also
- Five stocks we like better than Cochlear
- Coca-Cola Stock Is Everything AI Isn’t—And That’s Its Biggest Strength
- Apple’s Foldable iPhone Sold Out in Minutes, But Wall Street Has Questions
- Netflix Is Making Big Changes, But Can It Fix What’s Really Hurting Growth?
- Charging Ahead: Solid Power’s Pilot Line Leaves the Lab
Receive News & Ratings for Cochlear Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cochlear and related companies with MarketBeat.com's FREE daily email newsletter.
